Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
Lacutamab advances toward accelerated approval as ADC pipeline expands.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.